Genprex Inc (GNPX)
2.614
+0.17
(+7.13%)
USD |
NASDAQ |
May 06, 16:00
2.58
-0.03
(-1.30%)
After-Hours: 20:00
Genprex Free Cash Flow (Quarterly): -4.974M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.974M |
| September 30, 2023 | -4.757M |
| June 30, 2023 | -8.127M |
| March 31, 2023 | -6.952M |
| December 31, 2022 | -4.567M |
| September 30, 2022 | -4.539M |
| June 30, 2022 | -4.502M |
| March 31, 2022 | -4.074M |
| December 31, 2021 | -3.256M |
| September 30, 2021 | -2.602M |
| June 30, 2021 | -2.935M |
| March 31, 2021 | -5.575M |
| December 31, 2020 | -6.118M |
| September 30, 2020 | -1.978M |
| June 30, 2020 | -3.522M |
| March 31, 2020 | -4.654M |
| Date | Value |
|---|---|
| December 31, 2019 | -1.813M |
| September 30, 2019 | -1.948M |
| June 30, 2019 | -2.449M |
| March 31, 2019 | -1.655M |
| December 31, 2018 | -2.126M |
| September 30, 2018 | -1.477M |
| June 30, 2018 | -3.133M |
| March 31, 2018 | -0.2142M |
| December 31, 2017 | -0.2126M |
| September 30, 2017 | -0.659M |
| June 30, 2017 | -0.691M |
| March 31, 2017 | -0.6723M |
| December 31, 2016 | -0.8663M |
| September 30, 2016 | -0.2171M |
| June 30, 2016 | -0.0942M |
| March 31, 2016 | -0.1602M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.127M
Minimum
Jun 2023
-1.813M
Maximum
Dec 2019
-4.176M
Average
-4.502M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Lifecore Biomedical Inc | -- |
| Jaguar Health Inc | -7.451M |
| BioXcel Therapeutics Inc | -26.86M |
| TFF Pharmaceuticals Inc | -4.26M |
| 4D Molecular Therapeutics Inc | -25.20M |